The Campbell's Company filings document a New Jersey packaged-food issuer with capital stock listed on Nasdaq under CPB. Recent Form 8-K reports record quarterly operating results, amendments to revolving credit arrangements, senior unsecured note offerings under shelf registration materials, annual meeting voting results and financial or accounting leadership changes.
Proxy materials and related governance filings disclose board elections, auditor ratification, advisory executive-compensation votes, director and officer compensation programs, equity awards and shareholder voting mechanics. The filings also identify the company's Meals & Beverages and Snacks operating context, public-company capital structure and material agreements associated with its branded food portfolio.
Campbell's Co director Maria Teresa Hilado was granted 2,332.86 phantom shares on September 25, 2026. Each phantom share is the economic equivalent of one common share. Her reported post-transaction balance was 45,050.93 phantom shares, including 731.99 shares acquired through dividend reinvestment since her last report.
Campbell's Co (CPB) director Sarah Hofstetter acquired 2,155.39 fully vested Phantom Stock shares on September 25, 2026. Her reported direct position after the transaction was 36,610.87 Phantom Stock shares, including 590.41 shares acquired through dividend reinvestment since her last report. Each Phantom Stock share is the economic equivalent of one share of common stock. Its value is payable in cash from Campbell's Supplemental Retirement Plan upon her retirement, resignation or termination.
Campbell's Co. director Marc Bradley Lautenbach received a grant of 2,316.73 Phantom Stock shares on September 25, 2026. His reported post-transaction balance was 51,922.63 Phantom Stock shares. The value is payable in cash from the Company's Supplemental Retirement Plan upon his retirement, resignation or termination.
Campbell's Co director Keith R. McLoughlin acquired 4,414 Phantom Stock shares on September 25, 2026. The phantom shares are fully vested, and each is the economic equivalent of one share of common stock. Their value is payable in cash from the Supplemental Retirement Plan upon McLoughlin's retirement, resignation or termination. His reported Phantom Stock position after the transaction was 77,120 shares, including 1,246 shares acquired through dividend reinvestment since his last report.
Campbell's Co. director Archbold D. vanBeuren reported a grant/award acquisition of 2,333 common shares held indirectly through the ADvB Revocable Trust on September 25, 2026, at $0 per share. The trust's reported holdings after the award were 611,374 shares.
CAMPBELL'S Co director Grant Hill acquired 3,691 shares of Common Stock as a grant/award on September 25, 2026. His reported direct holdings after the transaction were 43,378 shares, including 676 shares acquired through dividend reinvestment since his last report.
Campbell’s Co. director and ten percent owner Mary Alice Dorrance Malone Jr. reported a grant/award acquisition of 2,155 common shares by Mary Alice Malone, Jr. Management Trust on September 25, 2026, at a reported price of $0.00 per share. The trust held 86,423 shares after the transaction; Malone is its beneficiary and co-trustee.
Campbell's Co director Kurt Schmidt acquired 3,691.28 fully vested Phantom Stock shares on September 25, 2026. Each share is the economic equivalent of one share of Campbell's Co common stock. His reported post-transaction balance was 63,347.88 Phantom Stock shares, including 1,022.24 shares acquired through dividend reinvestment since his last report. The value is payable in cash from the Company's Supplemental Retirement Plan upon his retirement, resignation or termination.
Campbell's Co director Howard M. Averill acquired 2,348.99 Phantom Stock shares on September 25, 2026. The phantom shares are fully vested, and each is the economic equivalent of one share of the company's common stock. Their value is payable in cash from the company's Supplemental Retirement Plan upon Averill's retirement, resignation or termination. His reported post-transaction Phantom Stock balance was 42,378.20 shares.
CPB reported fiscal 2026 net sales of $9.744 billion, compared with $10.253 billion in fiscal 2025; the periods were 52 and 53 weeks, respectively. Net earnings attributable to The Campbell's Company were $403 million, versus $602 million, and cash flows from operations were $1.039 billion, versus $1.131 billion. Capital expenditures totaled $361 million.
On May 4, 2026, CPB acquired 49% of La Regina for $146 million in cash. A second $140 million tranche is payable on May 4, 2027, at CPB’s discretion in cash or unregistered shares; the remaining 51% is subject to a call option granted to CPB and a put option granted to La Regina. Effective September 3, 2026, the board reset the quarterly dividend to $0.25 per share, payable November 2, 2026.
CPB expects input-cost inflation and volatility to persist in 2027. Its 2027 cost-savings initiatives are expected, once all phases are implemented, to generate approximately $500 million in annual ongoing savings by the end of 2030; identified pre-tax costs are approximately $90 million. CPB also has $500 million of senior notes maturing in March 2027 that it expects to repay and/or refinance.